Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Nippon India Mutual Fund raises stake in this healthcare stock. Do you own? - Mint
Nippon India Mutual Fund raises stake in this healthcare stock. Do you own?Mint
Laurus Labs Q4 Results: Cons PAT increased 19% to Rs 279 crore, revenue rises 5%
Laurus Labs reported a 19% year-on-year jump in net profit to Rs 279 crore for the March quarter, with revenue rising 5% to Rs 1,812 crore. Full-year net profit surged 148% to Rs 889 crore, driven by strong growth in its CDMO and Generics divisions. The company also announced an interim dividend of Rs 1.20 per share.
Multibagger stock hits record high, logs 10% intraday gain after Q4 results 2026
Mangalam Worldwide shares rose 9.33% to ₹351, driven by strong Q4 FY26 results. Net profit surged to ₹15.38 crore, while revenue from operations was ₹264.95 crore. The company declared a final dividend of ₹0.30 per share and plans a direct listing on BSE.
Godrej Agrovet Q4 profit jumps 48%, but margins take a hit
Godrej Agrovet Q4 results show strong profit and revenue growth but weaker margins, with a final dividend of ₹11 per share proposed for FY26. Shares of Godrej Agrovet ended higher on Thursday, by 1.11% at ₹600.00 on the NSE.
Indegene Q4 net profit falls 32% despite record ₹1,003 crore revenue, declares dividend
Shares of Indegene Ltd ended at ₹497.70, down by ₹2.05, or 0.41%, on the BSE.
Syngene International Q4 net profit falls 19%, but revenue up 2%; declares dividend
Shares of Syngene International Ltd ended at ₹432.30, down by ₹7.70, or 1.75%, on the BSE.
Granules India Announces Record Date for Final Dividend Distribution for FY26 - scanx.trade
Granules India Announces Record Date for Final Dividend Distribution for FY26scanx.trade
Where to invest now: SBI MF prefers large caps, pharma, PSU banks
Ruchit Mehta, Head of Research at SBI Mutual Fund, prefers CDMO and hospital plays within pharma, citing stronger growth prospects over generics. He sees large caps as attractive on valuations, while midcaps require selectivity amid earnings risks. PSU banks may outperform in the near term due to stronger loan growth, but asset quality risks could emerge over the next 2–3 quarters if global disruptions persist.
Sun Pharma Dividend Update: What 6.6 lakh retail holders need to know after Organon deal
At the end of the March quarter, Sun Pharma had a total of 6.6 lakh small retail shareholders, or those with an authorized share capital of up to ₹2 lakh. Starting February 2022, shareholders of Sun Pharma have received ₹62 per share as dividend payouts.
Holding 10 or more mutual funds? You may be over-diversified — here’s the ideal number
While there is no magical number, most wealth advisors and financial planners that Mint talked to recommended that 4-6 funds spread across asset classes and stock categories can take care of the majority of the needs of an investor.
Trent bonus issue announcement today; analyst against 'fresh buying'
Trent's board will consider and take a call upon a range of subjects in Wednesday's meeting, including the first-ever bonus share issuance and dividend for the financial year 2026.
AVI Polymers board to meet on Apr 27 to discuss results, dividend, mull healthcare entry
AVI Polymers board will meet April 27 2026 to approve FY26 audited results, consider up to 50 percent dividend, and review an AI led healthcare tech expansion via AVI AI Technologies